Diabetic Nephropathy and Diabetic Atherosclerosis
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 234
Special Issue Editors
2. Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
Interests: cardiovascular disease; diabetic nephropathy; atherosclerosis; inflammation; macrophage
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In our Special Issue on "Diabetic Nephropathy and Diabetic Atherosclerosis", we aim to provide a comprehensive exploration of the interrelated pathophysiological mechanisms, clinical manifestations, and therapeutic strategies for these critical complications of diabetes. Recent research has highlighted the intricate molecular pathways linking hyperglycemia with renal and vascular damage, emphasizing the role of inflammation, oxidative stress, and endothelial dysfunction. For this Special Issue, we seek to gather cutting-edge studies that elucidate novel biomarkers to aid in early detection, innovative pharmacological and non-pharmacological interventions, and evaluations of the impact of genetics on disease progression. By bridging gaps in the current knowledge, this Special Issue will advance our understanding of basic science and clinical practices and improve patient outcomes in diabetic nephropathy and atherosclerosis, fostering a holistic approach to managing diabetes-related complications.
Dr. Satyesh K. Sinha
Dr. Yuchen Wang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetic nephropathy
- diabetic atherosclerosis
- diabetes
- inflammation
- oxidative stress
- renal and vascular cell dysfunction
- basic science
- clinical practice
- patient outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
